We look forward to starting human studies with our lead compound in the near-term
In several RCTs, GLP-1RAs, when used alone or in combination with other hypoglycemic agents including metformin, sulfonylurea, DPP-4 inhibitor, thiazolidinedione, and sodium-glucose cotransporter 2 inhibitor, showed superior or non-inferior blood glucose lowering ability compared to insulin treatment [64,65]
These nutrient-rich foods contribute to a balanced diet and potentially hold benefits for supporting GLP-1 release and maintaining a healthy weight
For gastric tissue metabolites, the number of gastric tissue metabolites individually regulated by principal drug, assistant drug, and complement drug were 4, 0, and 1, respectively
Participants receiving tirzepatide achieved greater weight-loss milestones than those receiving semaglutide [3]
Scientifically shown to increase body stores of Glutathione by 30%+